Clients & Partners

We are proud to manage some of the leading global and regional brands.

About Us

Phoenix Clinical Research is a regional dynamic full-service Contract Research Organization (CRO) established in Lebanon. Its objective is to cover the whole Middle East and North Africa region.

Why Phoenix CR?

Phoenix Clinical Research is one of the very few full service CROs in the MENA region that is ISO accredited.

Phoenix Clinical Research combines the flexibility and responsiveness of its structure coupled with more than 18 years of international and regional expertise.

Phoenix CR was the first Clinical Research Organization (CRO) to monitor a Phase I study in Egypt.

Our team helped rescue several clinical trials in the region after handover from other international and regional clinical research organizations (CROs).

We are very known for the quality of our deliverables as we aim to bring the Swiss standards to the Middle East.


Have a Look at Our Latest News

Machine learning for diagnosis of myocardial infarction

High-sensitivity cardiac troponin assays have been included in the diagnostic approaches for patients with symptoms suggesting acute myocardial infarction 1,2. To improve diagnosis and overcome limitations associated with high-sensitivity cardiac troponin assays, a machine learning model was developed to integrate cardiac troponin concentrations at presentation

Read More »

RSV Vaccine During Pregnancy to Prevent RSV Infection in Infants

Human respiratory syncytial virus (RSV) is one of the common viruses that cause acute respiratory tract infection in infants and children leading to hospitalization 1,2. RSV infection mainly manifests as bronchiolitis and may progress to pneumonia 1,2. Symptoms include coryza, congestion, cough, and tachypnea. Worldwide,

Read More »

Arab Inclusion in Clinical Research

Clinical trials, which serve as the foundation of medical progress, possess the potential to revolutionize treatments and reshape the landscape of healthcare. Nonetheless, a significant gap remains apparent—a gap that undermines the core principle of fair medical advancement. The glaring absence of the Arab population

Read More »

Why MENA Region

  • Ideal to conduct genetic studies with high rates of consanguinity that could reach 70% in certain regions.
  • Western lifestyle habits increased the prevalence of cancer, cardiovascular and metabolic diseases.
  • GCC countries have the second highest prevalence of type 2 diabetes worldwide.
  • It has the highest incidence of pulmonary infections in the world.
  • Study start-ups can be achieved in less than three months in some countries.
  • The majority of investigators and study site staff are fluent in English.
  • Many Middle Eastern hospitals have been granted the Joint Commission International Accreditation.
  • The increase in life expectancy.